Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
Clinical Lymphoma Myeloma and Leukemia · 2025
DOI: 10.1016/j.clml.2024.10.005 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Frida Bugge Askeland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Oslo Myeloma Center, Oslo University Hospital, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, …. Hauptthemen laut MEDLINE: Autoimmune Diseases, Insulin, Insulin Antibodies, Plasma Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Monoclonal insulin autoimmune syndrome (IAS) is a very rare disease characterized by severe attacks of hypoglycemia caused by circulating anti-insulin antibodies produced by a B-cell clone, usually clonal plasma cells. METHOD: We present 2 female Norwegian patients with monoclonal IAS. The anti-insulin antibodies were quantified by immune precipitation and characterized using a 3-step manual in-house assay. Both patients received plasma cell directed therapy. RESULT: The first patient received plasma cell directed therapy for a time-limited period and achieved a sustained clinical remission without detectable anti-insulin antibodies. The second patient receives continuous plasma cell directed therapy and is in clinical remission with low values of detectable anti-insulin antibodies. CONCLUSION: Plasma cell directed therapy was effective and safe in our 2 cases of monoclonal IAS. We recommend considering plasma cell directed therapy for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Oslo Myeloma Center, Oslo University Hospital, Nydalen, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Blindern, Oslo, Norway. Electronic address: friask@ous-hf.no.
- Department of Haematology, Oslo Myeloma Center, Oslo University Hospital, Nydalen, Oslo, Norway.
- Department of Medical Biochemistry, Oslo University Hospital, Nydalen, Oslo, Norway.
- Department of Medical Biochemistry, Oslo University Hospital, Nydalen, Oslo, Norway; Hormone Laboratory, Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Nydalen, Oslo, Norway.
- Department of Endocrinology, Akershus University Hospital, Lørenskog, Norway.
- Institute of Clinical Medicine, University of Oslo, Blindern, Oslo, Norway; Department of Endocrinology, Akershus University Hospital, Lørenskog, Norway.
Zitieren
APA
Askeland, F. B., Frøen, H. M., Bolstad, N., Thorsby, P. M., Schjesvold, F., Wammer, A. C. P., Følling, I., & Tjønnfjord, G. E. (2025). Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.10.005
Vancouver
Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, et al. Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2024.10.005
BibTeX
@article{Askeland2025,
author = {Askeland, Frida Bugge and Frøen, Hege M and Bolstad, Nils and Thorsby, Per Medbøe and Schjesvold, Fredrik and Wammer, Anne Cathrine Parelius and Følling, Ivar and Tjønnfjord, Geir E},
title = {Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2025},
doi = {10.1016/j.clml.2024.10.005}
}
EUVIMED